News
Wunschanalyse Zalando
Herzlich Willkommen zu unserer Wunschanalyse in Zusammenarbeit mit Stephan Heibel vom Heibel-Ticker.de Börsenbrief (www.heibel-ticker.de).
Mit Hilfe von Predictive Analytics setzt sich
Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock
Bristol-Myers Squibb (NYSE: BMY) investors might have been just a bit worried on Wednesday. After all, the U.S. Food and Drug Administration (FDA) had just placed a partial clinical hold on three....
Embraer Secures Its 2018 Production With a Big E175 Order
Shares of Brazilian aircraft manufacturer Embraer (NYSE: ERJ) lost more than half of their value between late 2014 and mid-2017. Order activity for the company's commercial aircraft started to....
This Year's 12 Top-Selling Items on Amazon Prime Day
Image source: Amazon.com.Amazon.com (NASDAQ: AMZN) was rewarded with an overwhelming response to its annual Prime Day sales extravaganza this year. The company took the sale global this year and....
Auswertung Musterdepot KW 36/17
Musterdepot
Seit Auflage des Musterdepots am 16.06.2017 hat das Musterdepot einen Verlust von -1,05 Prozent eingefahren. Die Anfangssumme von 100.000 € wurde zu 37,6 Prozent in neun verschiedene....
Ford Is Still Struggling in China
Ford Motor Company (NYSE: F) said that its sales in China fell 1% in August from a year ago, as its mainstream models continued to struggle against newer competition from both domestic Chinese and....
Autonomous Ships Are Coming!
The autonomous-transportation revolution, ushered in by driverless cars, is spreading to the seas and other waterways. Autonomous cargo ships should be setting sail in the not-too-distance future,....
Roku IPO: What You Need to Know
Streaming media player maker Roku filed its S-1 Registration Statement with the Securities and Exchange Commission earlier this month, outlining its plans to go public in an $100 million initial....
BMW: 12 New Electric Cars to Challenge Tesla
BMW AG (NASDAQOTH: BAMXF) will launch 12 new all-electric vehicles between now and 2025, as part of a larger move into electrified drivetrains, the company said on Wednesday -- and it will unveil....
AbbVie Scores 2 Wins: 1 Threatens Regeneron
AbbVie (NYSE: ABBV) shares are rallying sharply following word that it won a victory against Coherus Biosciences (NASDAQ: CHRS) in a patent challenge and the release of positive late-stage trial....
3 Dividend Stocks for Retirement
In retirement, investors should be less worried about finding the next great growth stock and instead turn to looking for a steady stream of cash flows to fund their day-to-day expenses. Companies....
Now Guess Who's Getting Into Meal-Kit Delivery?
As if Blue Apron (NYSE: APRN) didn't have enough worries, now it has to contend with a new kind of competition: beverage makers entering the meal-kit delivery market. Coca-Cola (NYSE: KO)....
Why Is No One Talking About Canon Inc.'s Stock?
By any measure, Canon (NYSE: CAJ) is a pretty big deal. The well-known maker of cameras, printers, and other imaging systems has a market cap of roughly $46 billion, annual sales stand at a kingly....
Now We Know Why Apple Gave Such Strong Guidance
For many months now, the Apple Inc. (NASDAQ: AAPL) rumor mill has been working overtime, with reports that the newest version of the iPhone is facing production issues, resulting from a problem....
What Overshadowed GoPro's Guidance Update Today
GoPro Inc. (NASDAQ: GPRO) told investors during its second-quarter earnings report last month that it expected revenue of $290 million to $310 million in the third quarter and gross margin of 36%....
Ouch! Why Comcast Corp. Stock Was Slammed on Thursday
Shares of Comcast (NASDAQ: CMCSA) were hit hard on Thursday, falling as much as 7.2%. The stock finished the trading day down 6.2%.The stock's sharp sell-off comes as Comcast's vice president of....
Are These Healthcare Stocks Top Takeover Targets?
Following Gilead Sciences' (NASDAQ: GILD) decision to buy Kite Pharma (NASDAQ: KITE) for $11.9 billion in cash, we couldn't help but wonder what other healthcare stocks could be takeover targets,....
Apple Inc. To Debut New iPhones Next Week
For today’s bulletin, we take a look at Apple $AAPL ahead of their developer conference next week. We also provide a link to download a FREE STOCK REPORT on the company
VALUATION: Overvalued....
Payment Company Square Applies for Bank Charter
On Wednesday, The Wall Street Journal reported that payments company Square (NYSE: SQ) planned to submit an application on Thursday for a bank charter in Utah. The purpose of the unit, Square....
PepsiCo's "Simply" Line Wants to Do Business With Whole Foods
Once you let the idea sink in, organic Cheetos isn't as crazy as it seems.As Bloomberg reported last week, PepsiCo's (NYSE: PEP) Frito-Lay division has expanded a concept product line, known as....
Why Clovis Oncology Fell 7.1% in August
Shares of Clovis Oncology (NASDAQ: CLVS), a commercial-stage biotech focused on cancer, fell more than 7% in August, according to data from S&P Global Market Intelligence. The decline was owed....
Why I Love TerraForm Power, Inc.
TerraForm Power (NASDAQ: TERP) hasn't won the affection of investors since going public a few years ago, given that its stock is down nearly 60% over that timeframe. That said, the plunge isn't....
The End of Toys R Us Won't Be the End of Hasbro, Mattel, or JAKKS
The days may be numbered for Geoffrey the Giraffe, and investors of publicly traded toy makers are feeling the pinch. Shares of Hasbro (NASDAQ: HAS), Mattel (NASDAQ: MAT), and JAKKS Pacific....
Costco Stock: The Bear Case From a Bull
Costco (NASDAQ: COST) stock recently dipped into negative territory for the year to put it well behind the broader market's 10% increase. At first blush, the sell-off looks like shortsightedness....
Are You Buying Gilead Sciences, Inc. for the Wrong Reason?
Gilead Sciences (NASDAQ: GILD) is up about 12% over the last week or so since Novartis (NYSE: NVS) got its chimeric antigen receptor T-cell (CAR-T) therapy Kymriah approved by the FDA.That's just....